BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17441902)

  • 1. Plasticity in ligand recognition at somatostatin receptors.
    Robertson MJ; Meyerowitz JG; Panova O; Borrelli K; Skiniotis G
    Nat Struct Mol Biol; 2022 Mar; 29(3):210-217. PubMed ID: 35210615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease.
    Rol Á; Todorovski T; Martin-Malpartida P; Escolà A; Gonzalez-Rey E; Aragón E; Verdaguer X; Vallès-Miret M; Farrera-Sinfreu J; Puig E; Fernández-Carneado J; Ponsati B; Delgado M; Riera A; Macias MJ
    Nat Commun; 2021 Mar; 12(1):1869. PubMed ID: 33767180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide aromatic interactions modulated by fluorinated residues: Synthesis, structure and biological activity of Somatostatin analogs containing 3-(3',5'difluorophenyl)-alanine.
    Martín-Gago P; Rol Á; Todorovski T; Aragón E; Martin-Malpartida P; Verdaguer X; Vallès Miret M; Fernández-Carneado J; Ponsati B; Macias MJ; Riera A
    Sci Rep; 2016 Jun; 6():27285. PubMed ID: 27271737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues.
    Beierle JM; Horne WS; van Maarseveen JH; Waser B; Reubi JC; Ghadiri MR
    Angew Chem Int Ed Engl; 2009; 48(26):4725-9. PubMed ID: 19266506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances in the study of structure modification of somatostatin].
    Gong X; Han X; Wang DX
    Yao Xue Xue Bao; 2006 Nov; 41(11):1027-33. PubMed ID: 17262942
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
    Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
    J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
    Grace CR; Durrer L; Koerber SC; Erchegyi J; Reubi JC; Rivier JE; Riek R
    J Med Chem; 2005 Jan; 48(2):523-33. PubMed ID: 15658866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution.
    Gairí M; Saiz P; Madurga S; Roig X; Erchegyi J; Koerber SC; Reubi JC; Rivier JE; Giralt E
    J Pept Sci; 2006 Feb; 12(2):82-91. PubMed ID: 16365912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
    Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
    J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
    Kumar U
    J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.
    Nikiforovich GV; Marshall GR; Achilefu S
    Chem Biol Drug Des; 2007 Mar; 69(3):163-9. PubMed ID: 17441902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.